Atigen-Cell and Tissue Center

Atigen-Cell and Tissue Center is a specialized biotechnology entity and a subsidiary of NKMax (formerly ATGen), focused on the development and manufacturing of advanced cell-based immunotherapies. Based in South Korea, the center operates a high-standard GMP facility dedicated to the production of "Super NK" (SNK) cells, which are Natural Killer cells engineered for enhanced cytotoxicity and persistence. The center provides critical infrastructure for the group's clinical pipeline, supporting both autologous and allogeneic NK cell programs targeting oncology and neurodegenerative diseases. In addition to therapeutic development, the facility offers cell banking and tissue processing services to support personalized medicine initiatives. It serves as the primary manufacturing and R&D hub for NKMax's global cell therapy operations.